Skip to main content

Peer Review reports

From: Correlation between immune-related adverse events and therapeutic effects of nivolumab in patients with malignant pleural mesothelioma

Original Submission
13 Sep 2021 Submitted Original manuscript
28 Sep 2021 Reviewed Reviewer Report
5 Oct 2021 Reviewed Reviewer Report - Nobukazu Fujimoto
7 Oct 2021 Reviewed Reviewer Report
25 Oct 2021 Author responded Author comments - Yasuhiko Nishioka
3 Nov 2021 Reviewed Reviewer Report
10 Nov 2021 Reviewed Reviewer Report - Nobukazu Fujimoto
Resubmission - Version 2
25 Oct 2021 Submitted Manuscript version 2
Publishing
11 Nov 2021 Editorially accepted
15 Nov 2021 Article published 10.1186/s12890-021-01746-6

You can find further information about peer review here.

Back to article page